OBI PHARMA

Live / Registered — Registered and renewed (as of 21 Feb 2026)

What this means for you

Registered since 19 May 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2025).

Record

Serial number
86014025
Registration number
4737391
Mark type
Design + words
Filed
18 Jul 2013
Published for opposition
03 Mar 2015
Registered
19 May 2015
Next maintenance due
19 May 2025
Attorney of record
Michael T. Smith

Goods and services

  • Class 005 — Pharmaceuticals: [ Antibiotic preparations; Antibiotics; ] Anti-cancer preparations; [ Anti-infectives; Anti-inflammatories; ] Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; [ Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; ] Gastro-intestinal treatment preparations; [ In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; ] Medicinal preparations for the treatment of infectious diseases and for using in oncology; [ Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; [ Reagents and media for medical and veterinary diagnostic purposes; ] Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines

Owner

Prosecution history

  • 21 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 21 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 21 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 19 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 19 Nov 2025 — TEAS SECTION 8 & 9 RECEIVED
  • 19 May 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 27 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 27 Mar 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
  • 27 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 27 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 27 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 02 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 02 Apr 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 02 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 24 Sept 2021 — TEAS SECTION 8 RECEIVED

View this trademark record on Marksy